A Look At Exact Sciences (EXAS) Valuation After Its Strong Recent Share Price Momentum [Yahoo! Finance]
Exact Sciences Corporation (EXAS)
Last exact sciences corporation earnings: 2/11 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investor.exactsciences.com/investor-relations/default.aspx
Company Research
Source: Yahoo! Finance
Exact Sciences (EXAS) has drawn investor attention after a strong run over the past 3 months, with the move putting more focus on how its cancer screening and diagnostic business lines support the current share price. See our latest analysis for Exact Sciences. While the 1-day and 7-day share price returns have been slightly negative, Exact Sciences' 58.2% 90-day share price return and 82.7% 1-year total shareholder return suggest momentum has been building after a quieter year to date. If this kind of move has you looking beyond a single name, it could be a good time to scan other healthcare stocks that fit your own criteria. With Exact Sciences trading at US$102.26 and sitting close to an average analyst target near US$105.81, some models still imply roughly a 30% discount to intrinsic value. This raises the question: is this a genuine opportunity, or is the market already pricing in future growth? At a last close of $102.26 versus a narrative fair value of about $103.67,
Show less
Read more
Impact Snapshot
Event Time:
EXAS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
EXAS alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
EXAS alerts
High impacting Exact Sciences Corporation news events
Weekly update
A roundup of the hottest topics
EXAS
News
- Exact Sciences Corp. (EXAS) Rose Following the Acquisition Announcement [Yahoo! Finance]Yahoo! Finance
- Alger Small Cap Growth Fund Q4 2025 Portfolio Update [Seeking Alpha]Seeking Alpha
- Abbott posts Q4 sales below expectations [Yahoo! Finance]Yahoo! Finance
- Halper Sadeh LLC Encourages PEN, EXAS, DBRG, FFIC Shareholders to Contact the Firm to Discuss Their RightsGlobeNewswire
- $HAREHOLDER ALERT: The M&A Class Action Firm Is Investigating The Merger--PEN, DBRG, FFIC, and EXASPR Newswire
EXAS
Earnings
- 11/3/25 - Beat
EXAS
Sec Filings
- 1/30/26 - Form DEFA14A
- 1/23/26 - Form DEFA14A
- 1/9/26 - Form DEFM14A
- EXAS's page on the SEC website